RecruitingPhase 1NCT07682948

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

Sponsor

Korea United Pharm. Inc.

Enrollment

36 participants

Start Date

Jul 1, 2026

Study Type

INTERVENTIONAL

Conditions

Hypertension Dyslipidemia

Summary

A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers

Eligibility

Min Age: 19 YearsMax Age: 54 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Investigational Product 1, a drug called Investigational Product 1 + Investigational Product 2, and others for people with dyslipidemia and hypertension. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years to 54 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.